Symbol="LPCN"
AssetType="Common Stock"
Name="Lipocine Inc"
Description="Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah."
CIK="1535955"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="23012800"
EBITDA="-13313815"
PERatio="None"
PEGRatio="0"
BookValue="6.14"
DividendPerShare="0"
DividendYield="0"
EPS="-2.08"
RevenuePerShareTTM="0.107"
ProfitMargin="0"
OperatingMarginTTM="-24.01"
ReturnOnAssetsTTM="-0.204"
ReturnOnEquityTTM="-0.3"
RevenueTTM="554990"
GrossProfitTTM="500000"
DilutedEPSTTM="-2.08"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="36.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.356"
PriceToBookRatio="0.953"
EVToRevenue="441.02"
EVToEBITDA="-1.116"
Beta="0.965"
num_52WeekHigh="14.28"
num_52WeekLow="3.3"
num_50DayMovingAverage="4.553"
num_200DayMovingAverage="6.59"
SharesOutstanding="5206500"
DividendDate="None"
ExDividendDate="None"
symbol="LPCN"
open="4.25"
high="4.46"
low="4.25"
price="4.42"
volume="15003.00"
latest_trading_day="2023-07-07"
previous_close="4.30"
change="0.12"
change_percent="2.7644%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="82"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="163278"
Change_recent_avg="0.01"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.88"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="1124"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0157.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="605"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_positive_thumbnail_id_2="619"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
